B

Brown University Health

Remote behavioral health care platform analytics

Pharmacy Technician Specialist - Oncology Sterile Compounding

Full-Time
$25.42 - $26.50
Mid
Bachelor's
Providence, RI, USA
In Person
Medical, Clinical & VeterinaryPharmacy

About the job

Requirements
  • A high school diploma or equivalent degree is required.
  • Maintain current unrestricted Rhode Island Pharmacy Technician II licensure.
  • Maintain current National Pharmacy Technician Certification (CPhT).
  • Have at least 3 years of experience as a pharmacy technician, including 2 years of investigational, oncology, and/or sterile compounding experience, preferably in a similarly diverse and operationally complex health care environment.
  • Have knowledge of pharmacy information systems, automated dispensing technology, and personal computers.
  • Demonstrate written and verbal interpersonal and communication skills.
  • Be able to multitask and reprioritize while maintaining accuracy and service standards.
  • Obtain internal IV and oncology credentialing within 2 months of hire and maintain it at least semi-annually through successful completion of current competency assessments.
  • Be able to stand and walk for extended periods and have the visual and manual dexterity to operate a computer.
  • Travel between affiliates and sites occasionally as required.
Responsibilities
  • Ensure the sterile compounding environment and equipment are cleaned and maintained under aseptic conditions and in accordance with departmental standard operating procedures.
  • Perform hand hygiene and garbing practices in accordance with departmental standard operating procedures.
  • Perform sterile compounding of medications in compliance with USP 797, USP 800, National Institute for Occupational Safety and Health recommendations, and organizational policies and procedures.
  • Perform non-sterile compounding in compliance with USP 795, USP 800, National Institute for Occupational Safety and Health recommendations, and organizational policies and procedures.
  • Complete accurate documentation of compounded medications in accordance with organizational policies and procedures.
  • Perform sterile and non-sterile compounding of investigational medications in compliance with the specific investigational medication protocol.
  • Perform computer activities necessary for compounding, follow product documentation and check-process requirements, and document finished compounded medications accurately in accordance with policy.
  • Set up, calibrate, and operate ancillary compounding equipment, such as pumps.
  • Deliver compounded medication while meeting product stability-based storage requirements.
  • Collaborate with pharmacy oncology and purchasing teams to procure oncology and infusion medications and related supplies in a timely manner.
  • Collaborate with the pharmacy oncology team to segregate oncology and other hazardous medications.
  • Manage inventory by receiving, sorting, stocking, rotating stock, checking expiration dates, and disposing of items according to policy.
  • Track temperature monitoring and other applicable environmental controls for oncology and infusion medication storage, and triage out-of-range controls.
  • Transfer oncology and infusion medications to off-site satellite locations as necessary.
  • Perform recordkeeping and filing tasks and compile work-volume statistics.
  • Participate in orienting and training pharmacy technicians, student interns, and student externs.
  • Proactively help address issues affecting pharmacy oncology services.
  • Perform duties of other Pharmacy Technician job categories as required.
  • Act in accordance with the principles of the corporate compliance program and code of conduct.
Desired Qualifications
  • Completion of one to two years of college is preferred.

About the company

B

Brown University Health

View

Memoir Health provides a behavioral healthcare platform that enables home-based care for behavioral health and substance use issues. It helps health systems remotely manage patients with tools like remote patient monitoring, scheduling, virtual care, and outcomes management, powered by a data analytics engine that highlights cost-saving opportunities and supports automated workflows and one-click referrals. The platform differentiates itself by automating care journeys and delivering integrated, outcomes-focused care within managed care and other healthcare networks, reducing administrative workload for clinicians. Its goal is to make care more proactive, accessible, and coordinated from patients’ homes, improving outcomes while lowering costs, and Memoir Health was later acquired by Lumeo Health in 2020.

Company Size

1-10

Company Stage

Seed

Total Funding

$7.5M

Headquarters

New York City, New York

Founded

2018

Get referred to Brown University Health

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • A $37 million Starr Foundation alliance launched September 2026 for aging research.
  • Brown Health targets 30,000 new primary-care patients and 27 hires over three years.
  • Primary-care waitlists fell from 14,000 to 4,800, showing access improvements.

What critics are saying

  • UnitedHealthcare Medicare Advantage cutoffs hit 1,900 members in July 2026, hurting referrals.
  • A Massachusetts data breach investigation remains unresolved, exposing patient trust and regulatory risk.
  • Fiscal 2025 margin was 0.9%; weak reimbursement can trigger another existential liquidity squeeze.

What makes Brown University Health unique

  • Brown University Health unites Lifespan hospitals with Brown University academic medicine since 2025.
  • Its 2025 Brown Physicians merger added 500-plus physicians and 1,500-plus providers.
  • Epic, Workday, and Brown-aligned research integration create a larger operating platform.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Holidays

Paid Sick Leave

Productivity Bonus

Stock Options

Company Equity

Conference Attendance Budget

Wellness Program

Mental Health Support

Gym Membership

Phone/Internet Stipend

Home Office Stipend

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Parental Leave

Loan Assistance

Professional Development Budget

Education allowance

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Commuter Benefits

Meal Benefits

Medical Insurance

Life Insurance

Disability Insurance

Company News

Providence Business News
Apr 25th, 2023
Miriam Hospital’s palliative care program is first in R.I. and one of few in U.S.

LIFESPAN CORP. and HopeHealth launched the state’s first palliative care program in the emergency department of The Miriam Hospital.

Providence Business News
Jan 4th, 2023
Markell named New CFO of Lifespan Corp.

PETER K. MARKELL was named Lifespan Corp. ’s new chief financial officer and executive vice president, starting Jan. 30.

Providence Business News
Dec 26th, 2022
Pareek appointed chief of urology for Lifespan hospitals

PROVIDENCE – Lifespan Corp. has appointed Dr. Gyan Pareek as chief of urology in the department of surgery at Lifespan hospitals and president of Brown Urology Inc.

Providence Business News
Dec 15th, 2022
Lifespan Cancer Institute launches career program for young people of color

PROVIDENCE – The Lifespan Cancer Institute is launching a new program to train high school students of color for a career in cancer research and medicine.

Business Wire
Dec 15th, 2022
Trisalus Life Sciences Highlights Pressure-Enabled Regional Immuno-Oncology™ (Perio™) Clinical Trial Progress And Pre-Clinical Research Developments

DENVER & CHICAGO--(BUSINESS WIRE)--TriSalus Life Sciences®, Inc. (“TriSalus” or the “company”), an oncology company in the process of going public through a business combination transaction (the “Business Combination”) with MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or “MTAC”), today announced that it has expanded the reach of its ongoing Pressure-Enabled Regional Immuno-Oncology™ (“PERIO™-01” and “PERIO™-02”) clinical program.In recent months TriSalus has opened five new PERIO™-01 (NCT04935229) clinical trial sites, at Stanford University Hospitals, University of California Los Angeles, University of Colorado’s Anschutz Medical Campus, University of Washington Medical Center and University of Miami’s Sylvester Comprehensive Cancer Center, in addition to five previously activated sites. The PERIO™-01 trial is studying an investigational drug, SD-101, delivered intravascularly by the TriNav® Infusion System (“TriNav®”) using the company’s proprietary Pressure-Enabled Drug Delivery™ (“PEDD™”) method of administration. The study is evaluating whether this platform approach with SD-101 and PEDD™ can improve the performance of systemic checkpoint inhibitors in treating patients with uveal melanoma with liver metastases. In addition to these U.S. sites, TriSalus anticipates opening future PERIO™-01 clinical trial sites in the United Kingdom, Europe, and Canada.In parallel, TriSalus opened PERIO™-02 (NCT05220722) trial sites at Columbia University and University of Colorado Denver, along with Rhode Island Hospital – which was announced last month as part of an expanded research collaboration with Lifespan Health System